20 Jan (GAIA HEALTH) – GSK wanted to keep the public from knowing about the adverse effects of their Infanrix vaccine. The secret report slipped out, and it’s revealing. It validates the recent study showing that multiple vaccine doses increase the death rate by 50%—but there’s no real change to the safety advice.
by Heidi Stevenson
Infanrix is a vaccine that was released without any serious testing for safety, in spite of the fact that it contains antigens of six diseases for injection into babies as young as two months. In a cozy relationship with government, GlaxoSmithKline (GSK) was able to keep information about harm from the public. Fortunately, that secrecy was broken with the leak of this report given to the Belgian government. It delineates 1,742 adverse events associated with Infanrix.
These are adverse effects that were reported to GSK. The information is not pretty—especially when you realize that the vast majority of vaccine injuries are never reported and that deaths counted included only sudden death. First, though, let’s just take a quick look at what the report admitted happened over the two-year period from 23 October 2009 through 22 October 2011: That silly ol’ document showing all that nasty stuff that could happen? Don’t fret your little head over it! After all, you really weren’t supposed to know, anyway. Don’t worry. Trust us!
- 825 adverse effects were identified.
- 36 deaths occurred.
- Adverse events include autism, encephalitis, heart failure, gaze palsy (indicative of neurological damage), gastrointestinal hemorrhage, jaundice, mental retardation (classed as not serious!), removal of part of the intestine (also defined as not serious!), opisthotonos (yet again labeled as not serious!), paralysis. Guillain Barré syndrome, convulsions, and many others.
Naturally, not all the reported events were actually caused by Infanrix. GSK reported that the number of reported adverse events was only 14.6 per 100,000. However, as reported by Initiative Citoyenne, the doctors’ publication, Revue française du Practicien, reports that this figure is likely only 1-10% of the reality.
SPINNING AND TWISTING THE RESULTS
On page 11 of the report, GSK unequivocally states that they are the arbiters of what constitutes a serious event. As noted above, though, they classed mental retardation, opisthotonos, and removal of part of the intestine as not serious! You have to wonder just how twisted other aspects of the report might be—and we don’t need to go far to see. GSK decided to add only one reference of additional risk to their Reference Safety Information. The only thing they decided to add was syncope (fainting), and even then they attempted to minimize it by stating:
“Syncope (fainting) can occur following, or even before, any vaccination as a psychogenic response to the needle injection. It is important that procedures are in place to avoid injury from faints.“
They deprecate the seriousness of fainting, which can be indicative of severe adverse effects, such as neurological damage, by saying that any vaccination can cause it and, worse, that it’s just an emotional reaction. There seems to be no limit to the degree that GSK will go in its effort to whitewash Infanrix.
For more on this article go to GAIA Health
More from my site
Tags: Autism, autism vaccines, Big Pharma, GlaxoSmithKline, gsk infanrix, Guillain-Barré Syndrome, infanrix, infanrix gaze palsy, Infanrix Hexa, infanrix multivalent, infanrix opisthotonos, infanrix syncope, Initiative Citoyenne, REvue francaise du Practicien